Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study.

David T ArnoldMarie AttwoodShaney BarrattAnna MorleyKaren T ElversJorgen McKernonCharmaine DonaldAdrian OatesAlan NoelAlasdair MacGowanNick A MaskellFergus W Hamilton

Published in: Emergency medicine journal : EMJ (2021)

Admission blood biomarkers have only moderate predictive value for predicting COVID-19 outcomes, while simple clinical features such as age and NEWS2 score outperform many biomarkers. IL-6 and suPAR had the best performance, and further studies should focus on the additive value of these biomarkers to routine care.

Keyphrases

coronavirus disease
sars cov
emergency department
type diabetes
high intensity
metabolic syndrome
pain management
quality improvement
respiratory syndrome coronavirus
insulin resistance
case control
health insurance